摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-chloro-2-[(2-hydroxyethyl)amino]benzoic acid | 192719-21-4

中文名称
——
中文别名
——
英文名称
4-chloro-2-[(2-hydroxyethyl)amino]benzoic acid
英文别名
2-(2-hydroxyethylamino)-4-chlorobenzoic acid;4-chloro-2-(2-hydroxyethylamino)benzoic acid
4-chloro-2-[(2-hydroxyethyl)amino]benzoic acid化学式
CAS
192719-21-4
化学式
C9H10ClNO3
mdl
——
分子量
215.636
InChiKey
RVYFJXKJCXAZDB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    446.4±35.0 °C(Predicted)
  • 密度:
    1.463±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    69.6
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    2-AMINOBENZAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) INHIBITORS USEFUL FOR THE TREATMENT OF PAIN OR BLADDER FUNCTION DISORDER
    摘要:
    公开号:
    EP1955697B1
  • 作为产物:
    描述:
    2,4-二氯苯甲酸 、 、 C.I.酸性橙108盐酸 反应 4.5h, 以to give 20.9 g of 2-(2-hydroxyethylamino)-4-chlorobenzoic acid (IX) (yield, 97%)的产率得到4-chloro-2-[(2-hydroxyethyl)amino]benzoic acid
    参考文献:
    名称:
    Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
    摘要:
    一种制备式(V)的3-二卤苄基-2,4-喹唑啉二酮衍生物的方法:(其中X1,X2,X3分别独立为卤素原子,A为烷基),包括:将式(III)的二卤苄基衍生物(其中X2和X3如上所定义,L为酸残基)与具有羧基烷基的2,4-喹唑啉二酮衍生物反应(其中X1和A如上所定义),以选择性取代衍生物(1)的3位亚胺基的氢原子。以上方法能够有效制备上述式(V)的化合物,用于抑制醛糖还原酶,可以确保工人的安全和卫生,并可以促进废物处理以减少费用,因此在工业上极具优势。
    公开号:
    US06201121B1
点击查看最新优质反应信息

文献信息

  • 2-AMINOBENZAMIDE DERIVATIVE
    申请人:Kuramochi Takahiro
    公开号:US20090233900A1
    公开(公告)日:2009-09-17
    To provide a novel and excellent agent for treating or preventing nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like, based on the inhibitory action on the capsaicin receptor VR1 activation. The present invention was accomplished by confirming that a benzamide derivative characterized by the possession of a benzene ring in which a single ring is condensed on the nitrogen atom of amido group and possession of a lower alkylamino or an amino group substituted with a ring group at the neighboring position of said amido group has a strong inhibitory action on VR1 activation and excellent pharmacological actions based on this and by finding that it can become an excellent agent for treating or preventing VR1-involved diseases such as nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like.
    本发明提供了一种基于对辣椒素受体VR1激活的抑制作用的新型优良药剂,用于治疗或预防伤害性疼痛、神经病理性疼痛、癌症疼痛、头痛、膀胱功能障碍等疾病。本发明通过确认一种苯甲酰胺衍生物,其特征在于其苯环上的单环在酰胺基氮原子上被紧缩,其低烷基氨基或邻位于酰胺基的环基取代的氨基具有对VR1激活的强抑制作用和优良的药理作用,从而发现它可以成为治疗或预防伤害性疼痛、神经病理性疼痛、癌症疼痛、头痛、膀胱功能障碍等VR1相关疾病的优良药剂。
  • Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
    申请人:Fuji Chemical Industry Co., Ltd.
    公开号:US06201121B1
    公开(公告)日:2001-03-13
    A process for preparing a 3-dihalobenzyl-2,4-quinazolinedione derivative represented by the formula (V): (wherein X1, X2, X3 are independently a halogen atom, and A is an alkylene group), which comprises: reacting a dihalobenzyl derivative represented by the formula (III): (wherein X2 and X3 are each as defined above, and L is an acid residue) with a 2,4-quinazolinedione derivative having a carboxyalkyl group represented by the formula (I): (wherein X1 and A are each as defined above) to selectively substitute a hydrogen atom of an imino group at the 3-position of the derivative (1). The above process enables the efficient preparation of the compounds of the above formula (V) useful as inhibitors against aldose reductases, makes it possible to secure the safety and hygiene of workers, and can facilitate waste disposal to reduce the expenses, thus being industrially extremely advantageous.
    一种制备式(V)的3-二卤苄基-2,4-喹唑啉二酮衍生物的方法:(其中X1,X2,X3分别独立为卤素原子,A为烷基),包括:将式(III)的二卤苄基衍生物(其中X2和X3如上所定义,L为酸残基)与具有羧基烷基的2,4-喹唑啉二酮衍生物反应(其中X1和A如上所定义),以选择性取代衍生物(1)的3位亚胺基的氢原子。以上方法能够有效制备上述式(V)的化合物,用于抑制醛糖还原酶,可以确保工人的安全和卫生,并可以促进废物处理以减少费用,因此在工业上极具优势。
  • 2-aminobenzamide derivatives
    申请人:Astellas Pharma Inc.
    公开号:US08106190B2
    公开(公告)日:2012-01-31
    To provide a novel and excellent agent for treating or preventing nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like, based on the inhibitory action on the capsaicin receptor VR1 activation. The present invention was accomplished by confirming that a benzamide derivative characterized by the possession of a benzene ring in which a single ring is condensed on the nitrogen atom of amido group and possession of a lower alkylamino or an amino group substituted with a ring group at the neighboring position of said amido group has a strong inhibitory action on VR1 activation and excellent pharmacological actions based on this and by finding that it can become an excellent agent for treating or preventing VR1-involved diseases such as nociceptive pain, neuropathic pain, cancer pain, headache, bladder function disorder and the like.
    为了提供一种新颖且优秀的药剂,用于治疗或预防嗜痛性疼痛、神经病理性疼痛、癌症疼痛、头痛、膀胱功能障碍等,基于对辣椒素受体VR1激活的抑制作用。本发明通过确认一种苯甲酰胺衍生物,其特征在于其苯环上的单环在酰胺基团的氮原子上凝聚,并具有一个邻位取代环基的较低烷基氨基或氨基团,具有对VR1激活的强抑制作用和基于此的优异药理学作用,并发现它可以成为治疗或预防嗜痛性疼痛、神经病理性疼痛、癌症疼痛、头痛、膀胱功能障碍等VR1相关疾病的优秀药剂。
  • PROCESS FOR THE PREPARATION OF 3-DIHALOBENZYL-2,4-QUINAZOLINEDIONE DERIVATIVES
    申请人:FUJI CHEMICAL INDUSTRY CO., LTD.
    公开号:EP0896961A1
    公开(公告)日:1999-02-17
    A process for preparing a 3-dihalobenzyl-2,4-quinazolinedione derivative represented by the formula (V): (wherein X1, X2, X3 are independently a halogen atom, and A is an alkylene group), which comprises: reacting a dihalobenzyl derivative represented by the formula (III): (wherein X2 and X3 are each as defined above, and L is an acid residue) with a 2,4-quinazolinedione derivative having a carboxyalkyl group represented by the formula (I): (wherein X1 and A are each as defined above) to selectively substitute a hydrogen atom of an imino group at the 3-position of the derivative (I). The above process enables the efficient preparation of the compounds of the above formula (V) useful as inhibitors against aldose reductases, makes it possible to secure the safety and hygiene of workers, and can facilitate waste disposal to reduce the expenses, thus being industrially extremely advantageous.
    一种制备由式(V)代表的3-二卤苄基-2,4-喹唑啉二酮衍生物的工艺: 其中 X1、X2、X3 独立地为卤素原子,和 A为亚烷基)、 其中包括 使式 (III) 所代表的二卤代苄基衍生物反应: 其中 X2 和 X3 分别如上定义,以及 L 是酸残基) 与具有由式(I)表示的羧基的 2,4-喹唑啉二酮衍生物反应: 其中 X1 和 A 均如上所定义) 在衍生物 (I) 的 3 位选择性地取代一个亚氨基的氢原子。 上述工艺可以有效地制备作为醛糖还原酶抑制剂的上式(V)化合物,可以确保工人的安全和卫生,并可以方便地处理废物以减少开支,因此在工业上极为有利。
  • US6201121B1
    申请人:——
    公开号:US6201121B1
    公开(公告)日:2001-03-13
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐